KR910009328B1 - Process for preparation of 2-furylpurine derivatives - Google Patents
Process for preparation of 2-furylpurine derivatives Download PDFInfo
- Publication number
- KR910009328B1 KR910009328B1 KR1019890020246A KR890020246A KR910009328B1 KR 910009328 B1 KR910009328 B1 KR 910009328B1 KR 1019890020246 A KR1019890020246 A KR 1019890020246A KR 890020246 A KR890020246 A KR 890020246A KR 910009328 B1 KR910009328 B1 KR 910009328B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- furylpurine
- mmol
- amine
- cesium chloride
- Prior art date
Links
- LOUOPQKFUWJYSM-UHFFFAOYSA-N CC([O](C1OCCC1)=C)=O Chemical compound CC([O](C1OCCC1)=C)=O LOUOPQKFUWJYSM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
본 발명은 일반식(I)로 표시되는 2-푸릴퓨린의 새롭고도 진보된 제조방법에 관한 것으로 이들은 항종양작용을 나타내는 유기화합물이거나 이와 관련된 중요한 유기화합물이다.The present invention relates to a new and advanced process for preparing 2-furylpurine represented by general formula (I), which is an organic compound exhibiting antitumor action or an important organic compound related thereto.
일반식(I)에 있어서, X는 수소(-H), 아민(-NH2) 또는 티올(-SH)기이고; Y는 아민(-NH2), 염소(-Cl), 메틸티오(-SMe) 또는 수산기(-OH)이다. 바람직하게는, X가 수소인 경우, Y는 아민, 염소, 메틸티오 또는 수산기이고; X가 아민인 경우, Y는 아민 또는 수산기이며; X가 티올인 경우 Y는 아민이다.In formula (I), X is hydrogen (-H), amine (-NH 2 ) or thiol (-SH) group; Y is an amine (-NH 2 ), chlorine (-Cl), methylthio (-SMe) or hydroxyl group (-OH). Preferably, when X is hydrogen, Y is an amine, chlorine, methylthio or hydroxyl group; When X is an amine, Y is an amine or hydroxyl group; Y is an amine when X is a thiol.
일반식(I)의 퓨린 유도체의 공지 제조방법은 여러 문헌에 소개되고 있는 바, 대표적인 것을 인용하면 다음과 같다.Known preparation methods for the purine derivatives of general formula (I) have been introduced in various literatures.
[산 촉매를 사용하는 방법.][Method of using acid catalyst.]
6-벤질옥시퓨린을 p-TsOH 산 촉매를 사용하여 2,3-디히드로푸란과 반응시켜 결합시킨 후 Pd-C 촉매하에서 벤질기를 제거하여 9-(테트라히드로-2-푸릴) 히포잔틴을 얻고 있다. 그러나 이와 같은 방법은 퓨린 염기의 -OH나 -NH 등이 있는 경우 곧바로 사용될 수 없으므로 공정 단계가 많게 되고 따라서 수율도 낮은 것으로 보고되고 있다(W. A. Bowles. F. H. Schneider, L. Lewis, and R. K. Robins, J. Med. Chem., 471(1963)).6-benzyloxypurine was reacted with 2,3-dihydrofuran using p-TsOH acid catalyst to bind, and then benzyl group was removed under Pd-C catalyst to obtain 9- (tetrahydro-2-furyl) hipoxanthin. have. However, this method cannot be used immediately in the presence of -OH or -NH of the purine base, so the process steps are increased and thus the yield is reported to be low (WA Bowles. FH Schneider, L. Lewis, and RK Robins, J.). Med. Chem., 471 (1963).
본 발명은 종래의 공지 방법에서 내포하고 있던 여러 문제점들을 최소화하며, 고수율, 고순도로서 2-푸릴퓨린 유도체를 제조할 수 있으며, 최종 단계에서 목적산물의 분리가 용이한 새로운 제조방법을 제공하고자 하는 것이다. 본 발명자들은 결합시약(촉매)으로서 염화세슘을 사용하여 반응을 수행함으로써 그러한 목적이 성취될 수 있음을 밝혀내었다.The present invention minimizes the problems inherent in the conventional known methods, and can produce 2-furylpurine derivatives in high yield and high purity, and provides a new production method that is easy to separate the target product in the final step. will be. The inventors have found that such an object can be achieved by carrying out the reaction with cesium chloride as the binding reagent (catalyst).
본 발명에 의하여, 다음 일반식(II)의 퓨린 화합물을 트리메틸실릴화한 다음, 염화세슘을 촉매로 사용하여 유기용매 내에서, 일반식(III)의 2-아세톡시테트라히드로푸란과 반응시켜 일반식(I)의 2-푸릴퓨린을 제조하는 방법이 제공된다.According to the present invention, the purine compound of the following general formula (II) is trimethylsilylated, and then reacted with 2-acetoxy tetrahydrofuran of the general formula (III) in an organic solvent using cesium chloride as a catalyst. A method for preparing 2-furylpurine of formula (I) is provided.
일반식(II)에 있어서, X와 Y는 각각 앞서 일반식(I)에서 정의한 바와 같다.In the general formula (II), X and Y are as defined in the general formula (I).
좀더 상세히 설명하면, 일반식(II)의 퓨린 화합물을 실릴화제(바람직하게는 헥사메틸실라제인)와 함께 반응시켜 트리메틸실릴화된 화합물을 산출하고, 결과의 화합물을 유기용매(바람직하게는 아세토니트릴) 내에서 염화세슘 촉매 존재하에 일반식(III)의 2-아세톡시테트라히드로푸란과 반응시켜 일반식(I)의 2-푸릴퓨린 유도체를 제조하는 것이다. 염화세슘은 일반식(II)의 퓨린 화합물에 대하여 몰비로 약 0.1 : 1로 첨가되는 것이 바람직하다.In more detail, the purine compound of formula (II) is reacted with a silylating agent (preferably hexamethylsilase) to yield a trimethylsilylated compound, and the resulting compound is an organic solvent (preferably acetonitrile). And 2-acetyltetrahydrofuran of general formula (III) in the presence of a cesium chloride catalyst to prepare a 2-furylpurine derivative of general formula (I). Cesium chloride is preferably added in a molar ratio of about 0.1: 1 to the Purine Compound of Formula (II).
본 발명의 제조방법은 공지 방법들 보다 반응조건이 온화하고 최종단계에서 목적산물의 분리가 용이하며, 수율이 좋은 것으로 판명되었다. 특히 염화세슘은 공지의 다른 결합시약에 비해서 다루기가 간편하고 회수가 가능하여 2-푸릴퓨린 유도체 제조에 있어서 좋은 결합시약임을 보여 주었다.The production method of the present invention was found to be milder than the known methods, the reaction conditions are easy, the separation of the desired product in the final step, the yield is good. In particular, cesium chloride has been shown to be a good binding reagent in the preparation of 2-furylpurine derivatives because it is easier to handle and recoverable than other known binding reagents.
본 발명의 제조공정을 화학식으로 나타내면 다음과 같다.The manufacturing process of the present invention is represented by the following formula.
다음 실시예는 본 발명을 더욱 상세히 예증하여 줄 것이나 본 발명의 범위가 이에 국한된다는 것은 아니다.The following examples will illustrate the invention in more detail, but the scope of the invention is not limited thereto.
[트리메틸실릴화][Trimethylsilylated]
퓨린 화합물(II, 2mmol)을 헥사메틸디실라제인(HMDS, 10㎖)과 염화암모늄 촉매하에서 120-130℃ 온도에서 환류시킨다. 3-6시간 환류하면 반응용액은 투명한 상태가 되는데 여기서 과량의 HMDS를 감압증류로 회수한 후 실릴화된 화합물은 더 이상의 정제과정 없이 곧바로 다음 반응에 시용한다.Purine compound (II, 2 mmol) was refluxed at 120-130 ° C. under hexamethyldisilazane (HMDS, 10 mL) and ammonium chloride catalyst. After refluxing for 3-6 hours, the reaction solution becomes transparent, where the excess HMDS is recovered by distillation under reduced pressure, and the silylated compound is immediately applied to the next reaction without further purification.
[실시예 1]Example 1
9-(테트라히드로-2-푸릴) 아데닌의 제조Preparation of 9- (tetrahydro-2-furyl) adenine
트리메틸실릴화된 아데닌(2mmol)을 아세토니트릴(5㎖)에 녹이고 염화세슘(35mg, 0.2mmol)과 2-아세톡시테트라히드로푸란(390mg, 3mmol)을 넣은 후, 무수조건에서 5시간동안 상온에서 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(380mg, 92% 수율)을 수득하였다.Trimethylsilylated adenine (2 mmol) was dissolved in acetonitrile (5 mL), cesium chloride (35 mg, 0.2 mmol) and 2-acetoxy tetrahydrofuran (390 mg, 3 mmol) were added, followed by anhydrous conditions at room temperature for 5 hours. Stirred. The reaction mixture was concentrated and then chromatographed to give the desired product (380 mg, 92% yield).
[실시예 2]Example 2
9-(테트라히드로-2-푸릴)-2,6-디아미노퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -2,6-diaminopurine
트리메틸실릴화된 2,6-디아미노퓨린(2mmol)을 정제 아세토니트릴(5㎖)에 녹인 후 염화세슘(0.2mmol)과 2-아세톡시테트라히드로푸란(3mol)을 넣고 상온에서 약 4시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(440mg, 98% 수율)을 수득하였다.Trimethylsilylated 2,6-diaminopurine (2 mmol) was dissolved in purified acetonitrile (5 mL), followed by adding cesium chloride (0.2 mmol) and 2-acetoxy tetrahydrofuran (3 mol) at room temperature for about 4 hours. Stirred. The reaction mixture was concentrated and then chromatographed to give the desired product (440 mg, 98% yield).
[실시예 3]Example 3
9-(테트라히드로-2-푸릴)-6-클로로퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -6-chloropurine
트리메틸실릴화한 6-클로로퓨린(2mmol)을 정제 아세토니트릴(5ml)에 녹인 후 염화세슘(0.2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 넣고 상온에서 약 3시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(428mg, 96% 수율)을 수득하였다.Trimethylsilylated 6-chloropurine (2 mmol) was dissolved in purified acetonitrile (5 ml), cesium chloride (0.2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) were added, and the mixture was stirred at room temperature for about 3 hours. The reaction mixture was concentrated and then chromatographed to give the desired product (428 mg, 96% yield).
[실시예 4]Example 4
9-(테트라히드로-2-푸릴)-6-메틸티오퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -6-methylthiopurine
트리메틸실릴화한 6-메틸티오퓨린(2mmol)을 정제 아세토니트릴(5ml)에 녹인 후 염화세슘(0.2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 넣은 다음, 무수조건 하에서 상온에서 약 1.5시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(331mg, 98% 수율)을 수득하였다.Trimethylsilylated 6-methylthiopurine (2mmol) was dissolved in purified acetonitrile (5ml), cesium chloride (0.2mmol) and 2-acetoxytetrahydrofuran (3mmol) were added, and about 1.5 at room temperature under anhydrous conditions. Stir for hours. The reaction mixture was concentrated and then chromatographed to give the desired product (331 mg, 98% yield).
[실시예 5]Example 5
9-(테트라히드로-2-푸릴)-6-히드록시퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -6-hydroxypurine
트리메틸실릴화한 히포잔틴(2mmol)을 정제 아세토니트릴(5ml)에 녹인 후 염화세슘(2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 넣고 상온에서 약 5시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(494mg, 97% 수율)을 수득하였다.Trimethylsilylated hypoxanthine (2 mmol) was dissolved in purified acetonitrile (5 ml), cesium chloride (2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) were added and stirred at room temperature for about 5 hours. The reaction mixture was concentrated and then chromatographed to give the desired product (494 mg, 97% yield).
[실시예 6]Example 6
9-(테트라히드로-2-푸릴)2-티오아데닌의 제조Preparation of 9- (tetrahydro-2-furyl) 2-thioadenine
트리메틸실릴화된 2-티오-6-아미노퓨린(2mmol)을 정제 아세토니트릴( 5 ml)에 녹인 후 염화세슘(2mmol)과 2-아세톡시테트 라히드 로푸란 (3mmol)을 넣고 상온에서 약 4시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(70% 수율)을 수득하였다.Trimethylsilylated 2-thio-6-aminopurine (2 mmol) was dissolved in purified acetonitrile (5 ml), followed by adding cesium chloride (2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) at room temperature. Stir for hours. The reaction mixture was concentrated and then chromatographed to give the desired product (70% yield).
[실시예 7]Example 7
9-(테트라히드로-2-푸릴)구아닌의 제조Preparation of 9- (tetrahydro-2-furyl) guanine
트리메틸실릴화된 구아닌(2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 정제 아세토니트릴(5ml)내에서 상온에서 약 4시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(220mg, 50% 수율)을 수득하였다.Trimethylsilylated guanine (2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) were stirred in purified acetonitrile (5 ml) at room temperature for about 4 hours. The reaction mixture was concentrated and then chromatographed to give the desired product (220 mg, 50% yield).
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019890020246A KR910009328B1 (en) | 1989-12-29 | 1989-12-29 | Process for preparation of 2-furylpurine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019890020246A KR910009328B1 (en) | 1989-12-29 | 1989-12-29 | Process for preparation of 2-furylpurine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910011857A KR910011857A (en) | 1991-08-07 |
KR910009328B1 true KR910009328B1 (en) | 1991-11-11 |
Family
ID=19294295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890020246A KR910009328B1 (en) | 1989-12-29 | 1989-12-29 | Process for preparation of 2-furylpurine derivatives |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR910009328B1 (en) |
-
1989
- 1989-12-29 KR KR1019890020246A patent/KR910009328B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR910011857A (en) | 1991-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2010307562B2 (en) | Novel method for preparing entecavir and intermediate used therein | |
US4567254A (en) | Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
KR100213936B1 (en) | Process for the preparation of 2-amino-6-chloropurine which is a useful intermediate in the preparation of penciclovir or famciclovir | |
KR910009328B1 (en) | Process for preparation of 2-furylpurine derivatives | |
JPS61227583A (en) | Novel chemical process | |
CN114853648B (en) | Method for preparing asymmetric disulfide by NBS (N-bromosuccinimide) to promote breakage of thioether C-S bond | |
KR910009957B1 (en) | Process for preparation of 2-furyl pyrimidine derivatives | |
JPH0465053B2 (en) | ||
US11203573B2 (en) | N-alkylation of acridans | |
KR910000441B1 (en) | Process for the preparation of acyclic purine derivatives | |
KR900003090B1 (en) | Process for preparing aclylic pyrimidine derivatives | |
KR900007245B1 (en) | Process for the preparation of purine derivatives | |
JPH10130244A (en) | Production of acyclonucleoside | |
CN114478332B (en) | Synthesis method of alkyl trifluoromethyl sulfide | |
JPS5838284A (en) | Preparation of 1-(5'-oxohexyl)-3,7-dimethylxanthine | |
JPS6366176A (en) | Production of hydroquinone derivative | |
JPH10168068A (en) | Production of acyclonucleoside | |
KR100193368B1 (en) | Method for preparing riboflavin 5'-phosphate salt | |
KR100317615B1 (en) | A process for the preparation of 8-chloroadenosine 3',5'-cyclic monophosphate | |
KR820000785B1 (en) | Process for preparing 1-(tetrahydro-2-furanyl)-5-fluorouracil | |
KR900008169B1 (en) | Process for prparing acyclic pyrimidine derivatives | |
JPH0480918B2 (en) | ||
JPH10287657A (en) | Production of radiosensitizer | |
JP3012933B1 (en) | Dithianaphthalenophane compound and method for producing the same | |
KR860001817B1 (en) | Process for the preparation of ethyleneimine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19990630 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |